![Kathryn M. McNeil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathryn M. McNeil
No open positions remaining
Profile
Kathryn M.
McNeil worked as Head-Investor & Media Relations at Chelsea Therapeutics International Ltd. from 2009 to 2012.
She was also VP-Investor Relations & Public Relations at Novelos Therapeutics, Inc. from 2013 to 2014, and VP-Investor Relations & Corporate Communications at Cellectar Biosciences, Inc. from 2013 to 2015.
In 2017, she worked as Head-Communication & Investor Relations at Invitae Corp.
Ms. McNeil obtained an undergraduate degree from Wesleyan University.
Former positions of Kathryn M. McNeil
| Companies | Position | End |
|---|---|---|
| INVITAE CORPORATION | Public Communications Contact | 2018-03-31 |
| CELLECTAR BIOSCIENCES, INC. | Investor Relations Contact | 2015-07-27 |
Novelos Therapeutics, Inc.
 Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and provides pharmaceutical drugs | Investor Relations Contact | 2014-02-11 |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Investor Relations Contact | - |
Training of Kathryn M. McNeil
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
19
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company developing and commercializing therapeutics for a variety of human diseases | Health Technology |
Invitae Corp.
 Invitae Corp. Medical/Nursing ServicesHealth Services Provides genetic testing services for patients | Health Services |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and provides pharmaceutical drugs | Health Technology |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
- Stock Market
- Insiders
- Kathryn M. McNeil
